ATP2A2 and neoplasm: Binding of STING with VDAC2, ATP2A2, and ATP1A1 was confirmed in both A498 (Figure 3B; Figure S4B) and RCC10 (Figure 3C; Figure S4C, Supporting Information) tumor cells.